Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 2 diabetes.

Thomas R PieberMarisse AsongGabriele FluhrVera HöllerNiels R KristensenJonas H LarsenRasmus Ribel-MadsenEva SvehlikovaSiri VintherMargarete VoortmanHanne Haahr

Published in: Diabetes, obesity & metabolism (2023)

The pharmacokinetic and pharmacodynamic characteristics of icodec in individuals with T2D support its potential as a once-weekly basal insulin.

Keyphrases

type diabetes
glycemic control